In today’s briefing:
- Tencent (700 HK): DoD Says Chinese Military Company; Not on NS-CMIC List Yet
- Shinko Electric (6967 JP) – SAMR Approved, Trading Tight, Done Deal
- WH Group (288 HK): Smithfield’s IPO Doc Now Out
- GAPack (468 HK): IFA Says “Reject”. But Mengniu Selling Down
- Sigma Healthcare (SIG AU): Index Inclusions & Upweights Increase Passive Buying to A$2.7bn
- Henlius (2696 HK): Anxiety Creeping Back Ahead of the 22 January Vote
- US Defense Dept Designates Tencent and CATL as Military Companies – Impact on Korean Competitors
- Jiangsu Hengrui Pharma (600276 CH): Index Inclusion Post H-Share Listing
- LUNA Faces Nasdaq Delisting Amid Financial Restatement Delays and Strategic Review for Potential Sale
- EQD | S&P 500 (SPX Index) – An Options Strategy for 2025
Tencent (700 HK): DoD Says Chinese Military Company; Not on NS-CMIC List Yet
- The U.S. Department of Defense has designated Tencent (700 HK) as a Chinese Military Company. Tencent Holdings (ADR) (TCEHY US) shares were down nearly 8% overnight.
- There is no change to the Non-SDN Chinese Military-Industrial Complex Companies List (NS-CMIC) yet. But the overlap between the DoD list and the NS-CMIC list is high.
- If added to the NS-CMIC list, Tencent (700 HK) will be deleted from global indexes and there will be HUGE passive selling from these trackers.
Shinko Electric (6967 JP) – SAMR Approved, Trading Tight, Done Deal
- Overnight, we got news that the JIC Consortium Deal for Shinko Electric Industries (6967 JP) was approved 27Dec2024. That was the last approval required (other than TSE TOB Launch approval).
- This is “on schedule” or slightly early from the previously-announced expected launch date.
- This morning, the stock is up sharply and is trading <0.75% from terms. Expect an announcement within two weeks. Current arb annualised at high 6% is OK. One could hold.
WH Group (288 HK): Smithfield’s IPO Doc Now Out
- On 17 November 2024, WH Group (288 HK) announced an EGM to approve the spin-off and separately list subsidiary Smithfield Foods on the NYSE or NASDAQ.
- WHG, the world’s largest pork producer, announced on the 6th December the spin-off overwhelmingly gained shareholder approval.
- Yesterday, the Smithfield NASDAQ IPO doc was made public. As per the filing: “the number and dollar amount of Smithfield Shares to be offered and sold have not been determined“.
GAPack (468 HK): IFA Says “Reject”. But Mengniu Selling Down
- Quite a lot of new news to digest – GAPack (468 HK)‘s IFA, not altogether surprisingly, concluded that shareholders should not accept the Offer – in bold, red caps.
- But more surprisingly, is the disclosure announcement that China Mengniu Dairy Co (2319 HK) has reduced its stake below 5%.
- Evidently Mengniu is keeping its options open to tender – or not – and not have to make public disclosures. Keep an eye out on CCASS movements.
Sigma Healthcare (SIG AU): Index Inclusions & Upweights Increase Passive Buying to A$2.7bn
- SigmaHealthcare and ChemistWarehouse shareholders meet on 29 January. If the merger resolutions are approved, Second Court Hearing is on 3 February and the merger will be effective on 4 February.
- Upward migration in one large global index could take place on 13 February while upweights and upward migrations in the S&P/ASX indices should be at the close on 21 March.
- Upward migration in the other global index could take place in March or June. Total passive buying estimate is A$2.76bn. This will be offset by positioning and CWG shareholders selling.
Henlius (2696 HK): Anxiety Creeping Back Ahead of the 22 January Vote
- The vote on Fosun Pharma’s HK$24.60 offer for Shanghai Henlius Biotech (2696 HK) is on 22 January. The gross spread widened after the initial tightening due to the precondition satisfaction.
- Several readers have enquired about my thoughts on the widening spread. Our conversations have raised several potential concerns that could explain it.
- I think these concerns are unwarranted, and the vote should pass. At the last close and for a 15 February payment, the gross/annualised spread is 4.7%/55.0%.
US Defense Dept Designates Tencent and CATL as Military Companies – Impact on Korean Competitors
- The U.S. Department of Defense announced that it has added numerous Chinese companies including Tencent and CATL as companies that work with China’s military.
- This is likely to negatively impact Tencent and CATL’s prices in the next several weeks but positively impact on some of the major Korean rechargeable battery and gaming stocks.
- The higher probability scenario at this point is for Tencent and CATL to be officially included in the Chinese Military Industrial Complex list in the coming weeks.
Jiangsu Hengrui Pharma (600276 CH): Index Inclusion Post H-Share Listing
- Jiangsu Hengrui Medicine (600276 CH) has filed for a listing on the HKEX (388 HK) and reports indicate that the raise will be at least US$2bn.
- In line with the Midea Group (300 HK) and S.F. Holding (6936 HK) H-share listings, the discount on the H-shares could be in the 20-25% range.
- There will be no Fast Entry in any indices but there will be index inclusions in multiple indices if the raise is larger or once the cornerstone investor lock-up ends.
LUNA Faces Nasdaq Delisting Amid Financial Restatement Delays and Strategic Review for Potential Sale
- LUNA stock faced a 57% decline due to Nasdaq delisting notice, with trading volume 25 times the average.
- White Hat Capital Partners invested $50m in December 2023 and increased the loan facility to $30m in October 2024.
- Luna Innovations specializes in fiber optic sensing solutions, with notable contracts in aerospace, automotive, and oil & gas industries.
EQD | S&P 500 (SPX Index) – An Options Strategy for 2025
- The Insight presents two S&P 500 INDEX (SPX INDEX) options strategies for 2025. Call overwriting can generate premium income and potentially enhance returns in a choppy but mildly positive market.
- The second strategy is a Risk Reversal, using the proceeds from a short call to buy a protective put option, providing downside protection while still allowing for some upside potential.
- Both strategies are designed to align with the expected market conditions, considering factors such as inflation, economic growth, and market volatility.